Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of oral recombinant human chymotrypsin lyophilized powder for improving gastric mucosal visibility during gastroscopy
CTR20263965Phase 2Active
- Sponsor
- Wuhan Healthgen Biotechnology Corp.
- Start
- Oct 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Recombinant Human Chymotrypsin in None, sponsored by Wuhan Healthgen Biotechnology Corp.. Started Oct 2026; status: active.
02
Drugs
Recombinant Human Chymotrypsin
Beyond the preview
Go deeper on CTR20263965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263965.